People are central to our success. That’s why we offer benefits focused on supporting your comprehensive well-being—both inside and outside of work. Our benefits vary by region, but the goal is the ...

IVUS cuts costs and readmissions in venous stenting. Discover its value in outpatient procedures and learn more about the ...

In this issue of Circulation, Gao et al report the 1-year outcomes of ANGEL-REBOOT (Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel Occlusion), an ...

Christina is a freelance writer, registered dietitian, and sustainable food systems professional. She feels most passionately about improving the health of the planet and its people through sharing ...

The year 2025 marked a particularly transformational year for neurointervention. Beginning with the presentation of several neutral randomized distal and medium vessel occlusion (DMVO) clinical trials ...

Background Acute ischemic stroke due to large-vessel or medium-vessel occlusion is often treated with aspiration thrombectomy. Delivery-assist catheters (DAsCs) are a new class of tapered support ...

PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced successful Proof of Concept (POC) cases using its Clotild® Smart ...

Lawrenceville, Ga.-based Northside Hospital Gwinnett is the first hospital in Georgia, and the first in the U.S. outside a clinical trial, to use Emboline’s embolic protection catheter during a ...

The company’s robotic clot-sensing technology. [Image courtesy of Sensome] Sensome today announced proof-of-concept cases using its Clotild smart guidewire system with robotic thrombectomy technology.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get started with Staying Sharp. Follow this simple, flexible ...